This inventor holds 1 USPTO granted patent. Top assignee: Seoul National University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Ho Young Son: Innovator in Pharmaceutical Composition
Introduction
Ho Young Son is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that activate the RORα gene. His innovative work has implications for treating metabolic and inflammatory diseases.
Latest Patents
Ho Young Son holds a patent for "Thiourea derivatives as activators of RORα and pharmaceutical composition containing same." This patent describes a compound that activates the RORα gene, specifically a JC1 compound containing CGP52608 thiazolidinedione as a lead substance. The compound serves as a lipid accumulation inhibitor and is applicable in the treatment of various metabolic and inflammatory diseases. He has 1 patent to his name.
Career Highlights
Ho Young Son is affiliated with Seoul National University, where he conducts research and develops innovative pharmaceutical solutions. His work is characterized by a commitment to advancing medical science and improving patient outcomes through novel therapeutic approaches.
Collaborations
Some of his notable coworkers include Mi Ock Lee and Hyo Jun Jung, who contribute to his research endeavors and collaborative projects.
Conclusion
Ho Young Son's contributions to pharmaceutical innovation highlight the importance of research in developing new treatments for complex diseases. His work continues to inspire advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile